Skip to content
value.today

Sigma Pharmaceuticals Ltd

Pharmaceuticals

Formerly Arrow Pharmaceuticals Limited, Arrow Pharmaceuticals Pty Ltd

Total raised
$18 M
1 round on record
Latest round
$18 M
Sep 2009
First round on record
Sep 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sigma Pharmaceuticals Ltd
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2009$18 MNo. 1$10 to $50 million

Sigma Pharmaceuticals Ltd: Raise no. 1, Sep 2009

Investors in this round

13 investors had bought by the notice of Sep 24, 2009: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Over $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Australia

People named in the notice

  • Craig Tomlinson · Executive Officer · General Manager Merchandise & Marketing
  • Ian Finlay · Executive Officer · General Manager Operations
  • Jackie Toh · Executive Officer · Chief Information Officer and General Manager Wholesaling
  • James Barrie · Executive Officer · Commercial Finance and Investor Relations Manager
  • Keith Jeffs · Executive Officer · General Manager Orphan Australia
  • Mark Smith · Executive Officer · Chief Financial Officer
  • Michael Long · Executive Officer · General Manager Export and Contracts
  • Peter Tilley · Executive Officer · General Manager Retail Operations
  • Robert Ellis · Executive Officer · General Manager Business Development
  • Steve Waller · Executive Officer · General Manager - Consumer and Medical
  • Sue Morgan Dethick · Executive Officer · General Counsel and Company Secretary
  • Brian Jamieson · Director
  • David S Bayes · Director
  • Elmo de Alwis · Director · Managing Director
  • Geoffrey D W Curlewis · Director
  • John W Stocker AO · Director · Chairman
  • Linda B Nicholls · Director
  • William J Scott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Deutsche Bank Securities Inc. (CRD 2525) · broker-dealer Deutsche Bank Securities Inc. (CRD 2525) · New York, NySold in all US states

Signed by Sue Morgan Dethick, General Counsel and Company Secretary. Source: SEC Form D, newest notice filed Sep 24, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sigma Pharmaceuticals Ltd had revenue of over $100 million when it filed its newest notice of a funding round (Sep 2009).

    SEC Form D (revenue range) · Sep 2009

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2009

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sigma Pharmaceuticals Ltd is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sigma Pharmaceuticals Ltd
NameRoleNamed in
Craig TomlinsonGeneral Manager Merchandise & MarketingSep 2009
Ian FinlayGeneral Manager OperationsSep 2009
Jackie TohChief Information Officer and General Manager WholesalingSep 2009
James BarrieCommercial Finance and Investor Relations ManagerSep 2009
Keith JeffsGeneral Manager Orphan AustraliaSep 2009
Mark SmithChief Financial OfficerSep 2009
Michael LongGeneral Manager Export and ContractsSep 2009
Peter TilleyGeneral Manager Retail OperationsSep 2009
Robert EllisGeneral Manager Business DevelopmentSep 2009
Steve WallerGeneral Manager - Consumer and MedicalSep 2009
Sue Morgan DethickGeneral Counsel and Company SecretarySep 2009
Brian JamiesonDirectorSep 2009
David S BayesDirectorSep 2009
Elmo de AlwisManaging DirectorSep 2009
Geoffrey D W CurlewisDirectorSep 2009
John W Stocker AOChairmanSep 2009
Linda B NichollsDirectorSep 2009
William J ScottDirectorSep 2009